Premium
Substitution with doxorubicin for daunorubicin during induction for high risk pediatric acute lymphoblastic leukemia results in increased toxicity
Author(s) -
Gardner Rebecca A.,
Thomson Blythe,
Hawkins Douglas S.
Publication year - 2013
Publication title -
pediatric blood and cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.116
H-Index - 105
eISSN - 1545-5017
pISSN - 1545-5009
DOI - 10.1002/pbc.24325
Subject(s) - medicine , daunorubicin , hematology , family medicine , pediatrics , leukemia